• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带 POLE 突变的高突变肿瘤中的分子谱分析和连续体细胞突变转移。

Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.

机构信息

Medical Genetics Division, Shizuoka Cancer Center Research Institute, Sunto-gun, Shizuoka, 411-8777, Japan.

Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Sunto-gun, Shizuoka, 411-8777, Japan.

出版信息

Sci Rep. 2018 Jun 7;8(1):8700. doi: 10.1038/s41598-018-26967-4.

DOI:10.1038/s41598-018-26967-4
PMID:29880869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5992218/
Abstract

Defective DNA polymerase ε (POLE) proofreading leads to extensive somatic mutations that exhibit biased mutational properties; however, the characteristics of POLE-mutated tumours remain unclear. In the present study, we describe a molecular profile using whole exome sequencing based on the transition of somatic mutations in 10 POLE-mutated solid tumours that were obtained from 2,042 Japanese patients. The bias of accumulated variations in these mutants was quantified to follow a pattern of somatic mutations, thereby classifying the sequential mutation shift into three periods. During the period prior to occurrence of the aberrant POLE, bare accumulation of mutations in cancer-related genes was observed, whereas PTEN was highly mutated in conjunction with or subsequent to the event, suggesting that POLE and PTEN mutations were responsible for the development of POLE-mutated tumours. Furthermore, homologous recombination was restored following the occurrence of PTEN mutations. Our strategy for estimation of the footprint of somatic mutations may provide new insight towards the understanding of mutation-driven tumourigenesis.

摘要

DNA 聚合酶 ε(POLE)校对功能缺陷会导致广泛的体细胞突变,并表现出偏倚的突变特征;然而,POLE 突变肿瘤的特征仍不清楚。在本研究中,我们描述了一种基于 10 个 POLE 突变实体瘤体细胞突变的外显子组测序的分子谱,这些肿瘤来自 2042 名日本患者。对这些突变体中积累变异的偏倚进行了量化,以遵循体细胞突变的模式,从而将序贯突变转移分为三个时期。在发生异常 POLE 之前的时期,观察到与癌症相关基因的突变积累,而在该事件发生时或之后,PTEN 发生高频突变,提示 POLE 和 PTEN 突变是 POLE 突变肿瘤发生的原因。此外,PTEN 突变后同源重组得到恢复。我们估计体细胞突变足迹的策略可能为理解突变驱动的肿瘤发生提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/bbd3a73b893f/41598_2018_26967_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/d1ef5a16bc66/41598_2018_26967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/8d68114f7422/41598_2018_26967_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/3fef38ceb397/41598_2018_26967_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/80db87fcac51/41598_2018_26967_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/bbd3a73b893f/41598_2018_26967_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/d1ef5a16bc66/41598_2018_26967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/8d68114f7422/41598_2018_26967_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/3fef38ceb397/41598_2018_26967_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/80db87fcac51/41598_2018_26967_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed97/5992218/bbd3a73b893f/41598_2018_26967_Fig5_HTML.jpg

相似文献

1
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.携带 POLE 突变的高突变肿瘤中的分子谱分析和连续体细胞突变转移。
Sci Rep. 2018 Jun 7;8(1):8700. doi: 10.1038/s41598-018-26967-4.
2
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.体细胞 POLE 外切酶结构域突变是散发性子宫内膜癌和结直肠癌发生的早期事件,决定了驱动突变景观、克隆性新生抗原负担和免疫反应。
J Pathol. 2018 Jul;245(3):283-296. doi: 10.1002/path.5081. Epub 2018 Apr 30.
3
Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.不同 POLE 外切酶结构域突变体的突变过程驱动结直肠癌中特定 TP53 突变的富集。
PLoS Genet. 2020 Feb 3;16(2):e1008572. doi: 10.1371/journal.pgen.1008572. eCollection 2020 Feb.
4
High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.POLE 基因突变在同期子宫内膜癌和卵巢癌中的高频发生。
Hum Pathol. 2019 Mar;85:92-100. doi: 10.1016/j.humpath.2018.11.001. Epub 2018 Nov 15.
5
DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.DNA 聚合酶 ε 和 δ 外切酶结构域突变与子宫内膜癌。
Hum Mol Genet. 2013 Jul 15;22(14):2820-8. doi: 10.1093/hmg/ddt131. Epub 2013 Mar 24.
6
POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction.POLE 突变通过调节细胞代谢,经由 AMF/AMFR 信号转导,改善子宫内膜癌的预后。
BMC Med Genet. 2019 Dec 21;20(1):202. doi: 10.1186/s12881-019-0936-2.
7
High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.POLE 单等位基因突变的结直肠癌中存在高突变负担:不存在等位基因缺失和基因启动子甲基化。
Mod Pathol. 2020 Jun;33(6):1220-1231. doi: 10.1038/s41379-019-0430-6. Epub 2019 Dec 19.
8
Phenotype of POLE-mutated endometrial cancer.POLE 突变型子宫内膜癌的表型。
PLoS One. 2019 Mar 27;14(3):e0214318. doi: 10.1371/journal.pone.0214318. eCollection 2019.
9
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.结直肠癌中体细胞 POLE 校对结构域突变、免疫反应和预后:一项回顾性、汇总生物标志物研究。
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):207-216. doi: 10.1016/S2468-1253(16)30014-0. Epub 2016 Jul 20.
10
Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.癌症相关的DNA聚合酶ε P286R在裂殖酵母中的表达导致跨损伤合成聚合酶依赖性的超突变和有缺陷的DNA复制。
PLoS Genet. 2021 Jul 6;17(7):e1009526. doi: 10.1371/journal.pgen.1009526. eCollection 2021 Jul.

引用本文的文献

1
Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.先天性错配修复缺陷(CMMRD)综合征中的胶质瘤发生
Neurooncol Adv. 2024 Jul 11;6(1):vdae120. doi: 10.1093/noajnl/vdae120. eCollection 2024 Jan-Dec.
2
DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.DNA 聚合酶 ε 和 δ 变体在人类肿瘤中的多嘧啶序列中驱动突变。
Cell Rep. 2024 Jan 23;43(1):113655. doi: 10.1016/j.celrep.2023.113655. Epub 2024 Jan 13.
3
Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis.

本文引用的文献

1
The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.胞嘧啶甲基化与DNA复制及修复过程之间的相互作用塑造了癌症基因组的突变格局。
Nucleic Acids Res. 2017 Jul 27;45(13):7786-7795. doi: 10.1093/nar/gkx463.
2
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.结直肠癌中体细胞 POLE 校对结构域突变、免疫反应和预后:一项回顾性、汇总生物标志物研究。
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):207-216. doi: 10.1016/S2468-1253(16)30014-0. Epub 2016 Jul 20.
3
在肿瘤发生过程中,体细胞突变的成对和更高阶的上位效应。
Math Biosci. 2023 Dec;366:109091. doi: 10.1016/j.mbs.2023.109091. Epub 2023 Nov 22.
4
Case report: POLE (P286R) mutation in a case of recurrent intestinal leakage and its treatment.病例报告:一例复发性肠漏病例中的POLE(P286R)突变及其治疗
Front Oncol. 2023 Mar 16;13:1028179. doi: 10.3389/fonc.2023.1028179. eCollection 2023.
5
Molecular genetic positioning of small intestine and papilla of Vater carcinomas including clinicopathological classification.小肠和 Vater 乳头癌的分子遗传学定位,包括临床病理分类。
Cancer Med. 2023 May;12(10):11491-11502. doi: 10.1002/cam4.5877. Epub 2023 Mar 31.
6
Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.肝细胞癌中单个基因的多种突变的概述及临床意义。
BMC Cancer. 2022 Oct 5;22(1):1046. doi: 10.1186/s12885-022-10143-z.
7
Polymerase Epsilon-Associated Ultramutagenesis in Cancer.癌症中与聚合酶ε相关的超突变
Cancers (Basel). 2022 Mar 12;14(6):1467. doi: 10.3390/cancers14061467.
8
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.小鼠模型和人类患者数据揭示了Pten和p53在抑制POLE突变肿瘤发生中的关键作用。
NAR Cancer. 2022 Mar 3;4(1):zcac004. doi: 10.1093/narcan/zcac004. eCollection 2022 Mar.
9
Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation.直接作用抗病毒药物治疗实现持续病毒学应答后发生的肝细胞癌存在 TP53 失活。
Cancer Med. 2022 Apr;11(8):1769-1786. doi: 10.1002/cam4.4571. Epub 2022 Feb 17.
10
Clinical and Molecular Characterization of Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.基因突变的临床和分子特征可作为预测晚期癌症免疫检查点抑制剂疗效的生物标志物。
JCO Precis Oncol. 2022 Feb;6:e2100267. doi: 10.1200/PO.21.00267.
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
综合基因表达和拷贝数分析鉴定了 1454 个实体瘤中扩增依赖性过表达的潜在癌症驱动基因。
Sci Rep. 2017 Apr 4;7(1):641. doi: 10.1038/s41598-017-00219-3.
4
Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.全外显子组和409个癌症相关基因的综合下一代测序分析。
Biomed Res. 2016;37(6):367-379. doi: 10.2220/biomedres.37.367.
5
Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples.优化离子半导体测序数据分析方法以识别临床组织样本中癌细胞基因组中的体细胞突变。
Biomed Res. 2016;37(6):359-366. doi: 10.2220/biomedres.37.359.
6
The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.体细胞POLE P286R突变定义了一类具有高突变特征的独特结直肠癌亚类,代表了一种潜在的免疫治疗基因组生物标志物。
Oncotarget. 2016 Oct 18;7(42):68638-68649. doi: 10.18632/oncotarget.11862.
7
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.POLE 突变型子宫内膜癌中免疫激活及对帕博利珠单抗的反应
J Clin Invest. 2016 Jun 1;126(6):2334-40. doi: 10.1172/JCI84940. Epub 2016 May 9.
8
Genomic landscape of DNA repair genes in cancer.癌症中DNA修复基因的基因组格局
Oncotarget. 2016 Apr 26;7(17):23312-21. doi: 10.18632/oncotarget.8196.
9
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.DeconstructSigs:剖析单个肿瘤中的突变过程可区分DNA修复缺陷和癌演变模式。
Genome Biol. 2016 Feb 22;17:31. doi: 10.1186/s13059-016-0893-4.
10
Microsatellite Instability as a Biomarker for PD-1 Blockade.微卫星不稳定性作为 PD-1 阻断的生物标志物。
Clin Cancer Res. 2016 Feb 15;22(4):813-20. doi: 10.1158/1078-0432.CCR-15-1678.